Gatt Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
28
- Latest Deal Type
-
M&A
Gatt General Information
Description
Opeator of a medical supply company intended to be used for controlling severe injuries in patients. The company offers polymer-based general adhesive tissue tape for various surgical applications that help in hemostasis for thin anticoagulated blood and also proper adhesion to wet tissues, enabling healthcare professionals to avail tapes that can heal wounds and serve as a sealant after general surgery.
Contact Information
Website
www.gatt-tech.comCorporate Office
- Novio Tech Campus
- Transistorweg 5
- 6534 AT Nijmegen
- Netherlands
Corporate Office
- Novio Tech Campus
- Transistorweg 5
- 6534 AT Nijmegen
- Netherlands
Gatt Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 01-May-2022 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 15-Nov-2023 | Completed | Generating Revenue | |||
| 4. Grant | 06-Oct-2021 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 01-Jun-2021 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series B) | 18-May-2020 | $11.4M | $17.2M | Completed | Generating Revenue | |
| 1. Early Stage VC | 02-Oct-2012 | $5.8M | $5.8M | Completed | Generating Revenue |
Gatt Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Gatt Patents
Gatt Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240261461-A1 | System and methods for using tissue-adhesive porous hemostatic products with minimally invasive surgical techniques | Pending | 03-Feb-2023 | ||
| US-20240261462-A1 | System and methods for using tissue-adhesive porous hemostatic products with severe surface and cavity bleeding | Pending | 03-Feb-2023 | ||
| US-20240042094-A1 | Bioresorbable sealing powder | Pending | 08-Jan-2021 | ||
| WO-2022148725-A1 | Bioresorbable sealing powder | Inactive | 08-Jan-2021 | ||
| WO-2022023375-A1 | Bone-adhesive sheet | Inactive | 28-Jul-2020 | A61L24/0094 |
Gatt Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Gatt Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Commission | Government | |||
| European Innovation Council | Accelerator/Incubator | Minority | ||
| Johnson & Johnson JJDC | Corporate Venture Capital | Minority | ||
| Northstar Global Investment | PE/Buyout | |||
| Oost NL | Venture Capital | Minority |
Gatt FAQs
-
When was Gatt founded?
Gatt was founded in 2011.
-
Where is Gatt headquartered?
Gatt is headquartered in Nijmegen, Netherlands.
-
What is the size of Gatt?
Gatt has 28 total employees.
-
What industry is Gatt in?
Gatt’s primary industry is Medical Supplies.
-
Is Gatt a private or public company?
Gatt is a Private company.
-
What is Gatt’s current revenue?
The current revenue for Gatt is .
-
How much funding has Gatt raised over time?
Gatt has raised $27M.
-
Who are Gatt’s investors?
European Commission, European Innovation Council, Johnson & Johnson JJDC, Northstar Global Investment, and Oost NL are 5 of 6 investors who have invested in Gatt.
-
When was Gatt acquired?
Gatt was acquired on 01-May-2022.
-
Who acquired Gatt?
Gatt was acquired by Ethicon.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
